Nishant Mehta

Title: The Innovative Contributions of Nishant Mehta

Introduction

Nishant Mehta is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies with engineered IgG Fc domains. His work has implications for therapeutic applications and enhances our understanding of antibody interactions.

Latest Patents

Nishant Mehta holds a patent for "Antibodies with engineered IgG Fc domains." This patent describes antibody Fc polypeptides that efficiently bind to both Fcγ and Fcα receptors. The invention includes a Fc polypeptide that comprises a chimeric IgG CH2 domain featuring an α1 loop from IgA and an IgA CH3 domain. Additionally, recombinant antibodies that incorporate these Fc polypeptides, along with methods for their production and application, are also covered in the patent. He has 1 patent to his name.

Career Highlights

Nishant Mehta is affiliated with the University of Texas System, where he continues to advance research in antibody engineering. His work is pivotal in the development of novel therapeutic antibodies that can improve patient outcomes.

Collaborations

Nishant has collaborated with esteemed colleagues such as George Georgiou and William Kelton. These partnerships have fostered innovation and contributed to the success of his research endeavors.

Conclusion

Nishant Mehta's contributions to antibody engineering exemplify the impact of innovative research in biotechnology. His patent and collaborations highlight the importance of teamwork in advancing scientific knowledge and therapeutic solutions.